Sphera Funds Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-397,177	Closed	-$314K	–	115
2025 Q1	$314K	Hold	397,177	–	–	0.08%	109
2024 Q4	$655K	Buy	+397,177	New	+$1M	0.12%	99
2022 Q2	–	Sell	-89,425	Closed	-$3.47M	–	65
2022 Q1	$3.47M	Sell	89,425 -96,051	-52%	-$3.72M	0.58%	45
2021 Q4	$10.9M	Sell	185,476 -33,823	-15%	-$1.92M	1.29%	27
2021 Q3	$13M	Buy	219,299 +54,000	+33%	+$4.24M	1.29%	21
2021 Q2	$14.3M	Buy	165,299 +55,492	+51%	+$4.47M	1.3%	27
2021 Q1	$9.05M	Buy	109,807 +27,807	+34%	+$2.66M	0.83%	34
2020 Q4	$7.46M	Sell	82,000 -106,000	-56%	-$6.58M	0.77%	49
2020 Q3	$7.51M	Sell	188,000 -37,000	-16%	-$1.29M	0.87%	40
2020 Q2	$7.72M	Buy	+225,000	New	+$6.71M	0.92%	36